Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Reports Flat Q2 Revenues, Income

NEW YORK, July 28 - PerkinElmer reported nearly flat revenues and income for the second quarter last week, amid a dip in its life sciences revenues.


The company's revenues for the quarter totaled of $377.1 million, compared to $383.1 million for the second quarter of 2002.


The revenues for the company's life and analytical sciences business came to $246 million, compared to $250 million in the same period last year, Robert Friel, the company's chief financial officer, said in a conference call to discuss the company's quarterly results.


Income for the quarter was $8.4 million, compared to $9.1 million for the year-ago quarter.


The company's R&D expenses came to $21.9  million, compared to $22.6 million for the second quarter of 2002.


As of June 30, PerkinElmer had $144.6 million in cash and cash equivalents.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.